Baudax Bio, Inc. announced that it has entered into a share purchase agreement for the gross proceeds of $50 million on August 23, 2023. The transaction will include participation from new investor, Alumni Capital LP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0103 USD | -8.04% | -2.83% | -53.18% |
Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-53.18% | 540K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. announced that it expects to receive $50 million in funding from Alumni Capital LP